Search results for: 'NGS in CQA'

Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including potential, challenges, and drivers. This analysis e...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...

19 Jan 2024  |  Europe  |  Market Research

European Non-invasive Prenatal Testing Market, Forecast to 2028

Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe

Infographics

×

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional...

28 Jun 2024  |  Global  |  Market Research

Life Science Instrumentation and Research Tools Driving Transformational Growth through Automation Global, 2023 2029

A Steady Increase in Laboratory Budgets in Academia is Driving Innovation

Infographics

×

This study analyzes the life science instrumentation and research tools industry, covering the chemicals, consumables, instruments, reagents, suppliers, and IT solutions used in research laboratories. The global market for life science instrumentation and research tools is projected to experience steady growth from 2023 to 2029, achieving significa...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

20 Jun 2017  |  North America  |  Market Research

Transformation and Growth Opportunities in the US Next-Generation Sequencing Informatics Market

Pharmaceutical and Molecular Diagnostics Segments to Lead Revenue Growth

Infographics

×

Frost & Sullivan expects strong demand for commercial application-focused solutions to drive new investments in the development of tools and technologies, and will also result in consolidation of the US next-generation sequencing informatics market. Changing customer requirements and intense competition will drive the transformation. As companies l...